Azithromycin
- Generic Name
- Azithromycin
- Brand Names
- Azasite, Zithromax, Zmax
- Drug Type
- Small Molecule
- Chemical Formula
- C38H72N2O12
- CAS Number
- 83905-01-5
- Unique Ingredient Identifier
- J2KLZ20U1M
- Background
Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration . It was initially approved by the FDA in 1991 .
...
- Indication
Azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in order to prevent the development antimicrobial resistance and maintain the efficacy of azithromycin .
...
- Associated Conditions
- Acute Bacterial Sinusitis (ABS), Acute Otitis Media (AOM), Acute bacterial exacerbation of COPD caused by Haemophilus Influenza Infections, Moraxella Catarrhalis Infection, Streptococcus Pneumoniae Infections, Bacterial Conjunctivitis, Bacterial Sinusitis, Cervicitis, Chancroid, Community Acquired Pneumonia (CAP), Genital Ulcer Disease (GUD), Pelvic Inflammatory Disease (PID), Pharyngitis, Streptococcal Pharyngitis, Tonsillitis bacterial, Tonsillitis streptococcal, Traveler's Diarrhea, Uncomplicated Skin and Skin Structure Infections, Urethritis
- Associated Therapies
- -
Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Institute of Tropical Medicine, Belgium
- Target Recruit Count
- 42
- Registration Number
- NCT05027516
- Locations
- 🇧🇪
Institute of Tropical Medicine, Antwerpen, Belgium
Hypertonic Saline for MAC
- Conditions
- Interventions
- First Posted Date
- 2021-06-10
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 50
- Registration Number
- NCT04921943
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
🇨🇦University Health Network, Toronto, Ontario, Canada
🇺🇸Oregon Health & Science University, Portland, Oregon, United States
Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial)
- First Posted Date
- 2021-05-03
- Last Posted Date
- 2021-12-02
- Target Recruit Count
- 16
- Registration Number
- NCT04870138
- Locations
- 🇺🇸
University of North Carolina Health Care - Infectious Diseases, Chapel Hill, North Carolina, United States
EAT-DUTA AndroCoV Trial
- Conditions
- Interventions
- First Posted Date
- 2021-01-28
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- Corpometria Institute
- Target Recruit Count
- 138
- Registration Number
- NCT04729491
- Locations
- 🇧🇷
Corpometria Institute, Brasília, DF, Brazil
Infant Mortality Reduction by the Mass Administration of Azithromycin
- First Posted Date
- 2021-01-20
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 694400
- Registration Number
- NCT04716712
- Locations
- 🇧🇫
Helen Keller International, Ouagadougou, Burkina Faso
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇧🇫Centre de Recherche en Sante de Nouna, Nouna, Burkina Faso
The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children
- Conditions
- Interventions
- First Posted Date
- 2021-01-07
- Last Posted Date
- 2021-01-07
- Lead Sponsor
- Kayseri City Hospital
- Target Recruit Count
- 105
- Registration Number
- NCT04699097
- Locations
- 🇹🇷
Süleyman Sunkak, Kayseri, In The USA Or Canada, Please Select..., Turkey
Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
- Conditions
- Interventions
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Insmed Incorporated
- Target Recruit Count
- 99
- Registration Number
- NCT04677543
- Locations
- 🇪🇸
ESP002, Barcelona, Spain
🇪🇸ESP004, Madrid, Spain
🇪🇸ESP003, Barcelona, Spain
Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
- Conditions
- Interventions
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Insmed Incorporated
- Target Recruit Count
- 425
- Registration Number
- NCT04677569
- Locations
- 🇺🇸
USA014, Saint Petersburg, Florida, United States
🇺🇸USA084, Sebastian, Florida, United States
🇺🇸USA067, Tampa, Florida, United States
AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed At the Emergency Department
- First Posted Date
- 2020-12-16
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 1476
- Registration Number
- NCT04669288
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, United States
🇺🇸Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸Children's Hospital of New York Medical Center, New York, New York, United States
Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection
- Conditions
- Interventions
- First Posted Date
- 2020-11-10
- Last Posted Date
- 2020-11-10
- Lead Sponsor
- South Valley University
- Target Recruit Count
- 300
- Registration Number
- NCT04622891
- Locations
- 🇪🇬
south-Vally University faculty of medicine, Qena, Egypt
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.